دورية أكاديمية
أعرض في EDS

Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) meeting, virtual gathering, 26 February-1 March 2024.

التفاصيل البيبلوغرافية
العنوان: Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) meeting, virtual gathering, 26 February-1 March 2024.
المؤلفون: Lambach P; Immunizations, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland., Silal S; Modelling and Simulation Hub, Africa, University of Cape Town, Cape Town, South Africa; Centre for Global Health, Nuffield Department of Medicine, Oxford University, Oxford, United Kingdom., Sbarra AN; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States. Electronic address: asbarra1@jhu.edu., Koh M; Immunizations, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland., Aggarwal R; Jawaharlal Institute of Postgraduate Medical Education & Research, Puducherry, India., Farooqui HH; College of Medicine, QU Health, Qatar University, Qatar., Flasche S; Centre for Global Health, Charite, Berlin, Germany., Hogan AB; School of Population Health, University of New South Wales, Sydney, Australia., Kim SY; Seoul National University, Seoul, South Korea., Leung K; School of Public Health, The University of Hong Kong, Hong Kong Special Administrative Region., Moss WJ; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States., Munywoki PK; Kenya Medical Research Institute, Centre for Global Health Research, Nairobi, Kenya., Portnoy A; Department of Global Health, Boston University School of Public Health, Boston, United States; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, United States., Sheel M; School of Public Health, Faculty of Medicine and Health, University of Sydney, Sydney, Australia., Wang XY; Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China.
المصدر: Vaccine [Vaccine] 2024 May 31; Vol. 42 (15), pp. 3379-3383. Date of Electronic Publication: 2024 May 03.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
أسماء مطبوعة: Publication: Amsterdam, The Netherlands : Elsevier Science
Original Publication: [Guildford, Surrey, UK] : Butterworths, [c1983-
مواضيع طبية MeSH: World Health Organization* , Advisory Committees* , Malaria Vaccines*/administration & dosage , Malaria Vaccines*/immunology, Humans ; Cost-Benefit Analysis ; Vaccination/methods ; Malaria/prevention & control ; Immunization/methods
مستخلص: The Immunization and Vaccine-related Implementation Research Advisory Committee (IVIR-AC) is the World Health Organization's key standing advisory body to conduct an independent review of research, particularly of transmission and economic modeling analyses that estimate the impact and value of vaccines. From 26th February-1st March 2024, at its first of two semi-annual meetings, IVIR-AC provided feedback and recommendations across four sessions; this report summarizes the proceedings and recommendations from that meeting. Session topics included modeling of the impact and cost-effectiveness of the R21/Matrix-M malaria vaccine, meta-analysis of economic evaluations of vaccines, a global analysis estimating the impact of vaccination over the last 50 years, and modeling the impact of different RTS,S malaria vaccine dose schedules in seasonal settings.
Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: S. S. was supported by the World Health Organization for this work. A. N. S. was financially supported by the World Health Organization for this work, and is additionally supported by the Bill & Melinda Gates Foundation, Gavi, the Vaccine Alliance, and the National Institutes of Health. A. B. H. was supported by the Australian National Health and Medical Research Council for this work, is additionally supported by PATH, the World Health Organization, and Gavi, the Vaccine Alliance, and has received consulting fees from the Australian NSW Ministry of Health, WHO Europe and Asian Development Bank. W. J. M. is supported by the National institutes of Health. A. P. is supported by Imperial College London, the Bill & Melinda Gates Foundation, the World Health Organization, and the University of Oslo. X. W. has served as a Data Safety Monitoring Board member for several China-made COVID-19 vaccines. S. S., A. N. S., and A. B. H. report travel related support from the World Health Organization to attend previous IVIR-AC meetings. All other authors have no declarations.
(Copyright © 2024. Published by Elsevier Ltd.)
التعليقات: Erratum in: Vaccine. 2024 Jul 11:S0264-410X(24)00743-6. doi: 10.1016/j.vaccine.2024.07.003. (PMID: 38991915)
References: EClinicalMedicine. 2022 Apr 21;47:101410. (PMID: 35497069)
Vaccine. 2024 Mar 7;42(7):1424-1434. (PMID: 38326131)
Lancet. 2016 Jan 23;387(10016):367-375. (PMID: 26549466)
Vaccine. 2023 Aug 1;:. (PMID: 37537094)
Lancet. 2024 Feb 10;403(10426):533-544. (PMID: 38310910)
PLoS One. 2021 Dec 20;16(12):e0260808. (PMID: 34928971)
Lancet Infect Dis. 2024 May;24(5):465-475. (PMID: 38342107)
Open Forum Infect Dis. 2019 Mar 08;6(4):ofz117. (PMID: 31049363)
Value Health. 2023 Apr;26(4):598-611. (PMID: 36328324)
Lancet Glob Health. 2022 Dec;10(12):e1782-e1792. (PMID: 36400084)
Vaccine. 2022 Jun 21;40(28):3903-3917. (PMID: 35643565)
معلومات مُعتمدة: 001 International WHO_ World Health Organization
فهرسة مساهمة: Keywords: EPI; Economic evaluation; IVIR-AC; Malaria; Meta-analysis
تواريخ الأحداث: Date Created: 20240504 Date Completed: 20240519 Latest Revision: 20240711
رمز التحديث: 20240712
مُعرف محوري في PubMed: PMC11128797
DOI: 10.1016/j.vaccine.2024.04.057
PMID: 38704250
قاعدة البيانات: MEDLINE
الوصف
تدمد:1873-2518
DOI:10.1016/j.vaccine.2024.04.057